Arbuckle Stuart A bought VRTX

February 7, 2024 · Form 4 insider transaction

Arbuckle Stuart A bought 8,448 shares of Vertex Pharmaceuticals Incorporated at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction

Acquired (buy-side)

8,448

Price

$0.00

Total value

N/A

InsiderArbuckle Stuart A

RoleDirector

CompanyVertex Pharmaceuticals Incorporated (VRTX)

SecurityCommon Stock

Transaction codeA — Grant or award

Transaction dateFebruary 7, 2024

Filing dateFebruary 8, 2024

Shares owned after83,190

OwnershipDirect

10b5-1 planNo

AmendedNo

Footnotes

Restricted stock unit award that vests in installments beginning on 02/17/2025.

View the original Form 4 on SEC EDGAR